dr. bekaii-saab discusses qol with regorafenib dose escalation in mcrc
Published 6 years ago • 74 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
1:21
dr. bekaii-saab discusses regorafenib use in mcrc
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
1:39
dr. bekaii-saab on dosing strategies with regorafenib in crc
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
1:28
pancreatic cancer surgery: is the patient age relevant? | prof buechler - champalimaud foundation
-
10:47
sivan kijner - the infant gut commensal bacteroides dorei presents a generalized tran.. | s01 mvif10
-
3:09
pancreatic cancer: treatments, risks of surgery and risk minimization | prof buechler
-
0:57
dr. bekaii-saab discusses the next steps with regorafenib in crc
-
1:21
tanios bekaii-saab, md: regorafenib dose adjustments
-
2:27
dr. bekaii-saab on the redos study in metastatic colorectal cancer
-
1:27
tanios bekaii-saab, md, comments on dosing regorafenib (stivarga) in 3rd line treatment of mcrc
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
2:24
dr. bekaii saab compares toxicities of regorafenib and tas-102 in colorectal cancer
-
0:28
tanios bekaii-saab, md: reinitiating regorafenib in patients with mcrc
-
2:26
dr. bekaii-saab on the impact of regorafenib in crc
-
5:31
practical advice for using regorafenib
-
1:20
tanios bekaii-saab, md: clinical data supporting regorafenib in mcrc
-
1:12
tanios bekaii-saab, md: mechanisms of action in regorafenib
-
7:08
the regorafenib dose optimization study
-
1:23
dr. bekaii-saab on benefits associated with regorafenib or tas-102 for crc
-
14:37
progress report v - ruben borbély